Connect with us

Covid

Does menstruation limit the Covid vaccine’s potency? 

Published

on

Does menstruation limit the Covid vaccine’s potency? 

Social media is abuzz with lots and lots of news regarding the value of the Covid-19 vaccine and it’s power on people. Also, many posts are floating around regarding it’s potency in women, who are menstruating, saying that it lowers the immunity. And hence, taking the vaccine five days before, during or after your periods won’t be safe.

Not just this, a few other posts mentioned that the first dose of the vaccine decreases immunity and later gets to built up.

According to Dr Divya Swetha, Consultant at Obsterics & Gynaecology, Ankura Hospitals, Madinaguda (Hyderabad), vaccines are absolutely safe during periods.

She says, “Period or no period, get your vaccination.”

She further added that there is no data or study validating this claim and it is safely recommended for all women above 18 excluding pregnant and breastfeeding mothers.

For further queries or online consultation, please contact –

Name – Dr Divya Swetha

Contact number – +91 40 4939 9999

Covid

Covid-19 in India: 18,987 new cases in last 24 hours, 20% higher than day before

Published

on

By

Covid-19 in India: 18,987 new cases in last 24 hours, 20% higher than day before

The Union Ministry of Health and Family Welfare (MoHFW) said on Wednesday said that India registered 18,987 new Covid-19 cases in the last 24 hours, which was 20 per cent higher than what the country had witnessed a day before.

Also, total of 246 deaths were reported during the same time, increasing the total reported death count to 4,51,435.

With this, the total Covid caseload in India has increased to 3,40,20,730.

The top five states which have registered maximum cases are Kerala with 11,079 cases, followed by Maharashtra with 2,219 cases, Tamil Nadu with 1,280 cases, Mizoram with 1,028 cases and West Bengal with 771 cases.

Continue Reading

Covid

Covaxin gets emergency use approval for kids aged 2-18 years

Published

on

By

Covaxin gets emergency use approval for kids aged 2-18 years

The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech’s Covaxin for children in the 2-18 years age group.

In September, Hyderabad-based Bharat Biotech had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of age and also submitted the trial data to the Drugs and Comptroller General of India (DCGI).

“After detailed deliberation, the committee recommended for grant of market authorization of the vaccine for the age group of 2 to 18 years for restricted use in emergency situation,” the subject expert panel said in a statement.

 

Continue Reading

Covid

Govt has no data of Covid-19 vaccines given daily by private hospitals

Published

on

By

Govt has no data of Covid-19 vaccines given daily by private hospitals

The Union health ministry has said that it does not hold data of daily Covid-19 vaccines doses administered by private hospitals and health service providers.

In a response to RTI petition and appeal filed by activist Commodore (Retd) Lokesh Batra, the government has said the same

In its first reply, the government mentioned, “Private hospitals/institutions etc procure vaccines directly from the vaccine manufacturers. Data asked pertains between manufacturers and private hospitals/institutions etc. Separate vaccination data is not available, however, the vaccination data ll date can be checked on the below link hps://dashboard.cowin.gov.in/ (sic).”

“This information is not maintained and is not available since procurement of vaccines by private hospitals private healthcare service providers and private entities are done directly from the manufacturers,” the Union health ministry said.

Continue Reading

Trending